Sotret

Rediff.com » News » Sotret

News for Sotret

Business

Ranbaxy may reduce global sales team

Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third.A majority of the job cuts would be in the US, it is......

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India's top drugmaker agreed to pay a hefty $500 million......

Ranbaxy to pay $500 mn to settle US fraud charges

The country’s biggest drugmaker, Ranbaxy Laboratories on Monday agreed to pay $500 million (around Rs 2,743 crore) to resolve fraud allegations made in a whistle-blower’s lawsuit and......

Ranbaxy recalls skin care drug from UK

Ranbaxy Ltd has been asked by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the largest drug regulator in Europe, to recall its drugs used to treat skin infections.Ranbaxy (UK)......

Ranbaxy recalls 3 drugs from European markets

Ranbaxy Laboratories on Wednesday said its European subsidiary is recalling select batches of three drugs, including two anti depressants, from Britain, Ireland and Denmark for updating safety......

Rediff News

Sotret

News for Sotret

Ranbaxy may reduce global sales team

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy to pay $500 mn to settle US fraud charges

Ranbaxy recalls skin care drug from UK

Ranbaxy recalls 3 drugs from European markets

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS